A new approach for early cancer treatment known as radioligand therapy (RLT) has been shown to reduce the risk of advanced neuroendocrine tumour progression and death by 72 per cent in otherwise challenging areas to treat.
Read full story
Research news
Wednesday, June 12, 2024 Inaugural SRI Research Day highlights leading research across all platforms
The first-ever Sunnybrook Research Institute (SRI) Research Day, hosted by the SRI Student Network (SSN) on June 10th, showcased leading research from scientists, trainees and students across SRI’s biological, physical and evaluative clinical sciences platforms.
Read full story
The first-ever Sunnybrook Research Institute (SRI) Research Day, hosted by the SRI Student Network (SSN) on June 10th, showcased leading research from scientists, trainees and students across SRI’s biological, physical and evaluative clinical sciences platforms.
Read full story
Wednesday, June 5, 2024 New cancer treatment significantly reduces tumour progression and death
A new approach for early cancer treatment known as radioligand therapy (RLT) has been shown to reduce the risk of advanced neuroendocrine tumour progression and death by 72 per cent in otherwise challenging areas to treat.
Read full story
A new approach for early cancer treatment known as radioligand therapy (RLT) has been shown to reduce the risk of advanced neuroendocrine tumour progression and death by 72 per cent in otherwise challenging areas to treat.
Read full story
Tuesday, June 4, 2024 New study shows equity-deserving populations feel Virtual Emergency Department (ED) promotes cultural safety
A new Sunnybrook-led study published in PLOS ONE has found that members from equity deserving populations (EDPs) preferred virtual emergency healthcare under certain circumstances as they found the Virtual ED to be a more socially and culturally safe space with improved access compared to their experiences of in-person ED care.
Read full story
A new Sunnybrook-led study published in PLOS ONE has found that members from equity deserving populations (EDPs) preferred virtual emergency healthcare under certain circumstances as they found the Virtual ED to be a more socially and culturally safe space with improved access compared to their experiences of in-person ED care.
Read full story
Monday, June 3, 2024 Sunnybrook Inventors: Dr. Brian Courtney
Sunnybrook inventors like Dr. Brian Courtney, clinician-scientist in the Schulich Heart Program and co-founder of Conavi Medical are trailblazing patient care one idea at a time by working with partners to bring discoveries to the medical marketplace so they reach more patients.
Read full story
Sunnybrook inventors like Dr. Brian Courtney, clinician-scientist in the Schulich Heart Program and co-founder of Conavi Medical are trailblazing patient care one idea at a time by working with partners to bring discoveries to the medical marketplace so they reach more patients.
Read full story
Thursday, May 23, 2024 AI in Action: The AI landscape at Sunnybrook
While the idea of artificial intelligence (AI) may seem new to many of us, researchers like Anne Martel have been working with it for decades. Martel gives an insider’s perspective to this evolving field as part of our ongoing AI In Action series.
Read full story
While the idea of artificial intelligence (AI) may seem new to many of us, researchers like Anne Martel have been working with it for decades. Martel gives an insider’s perspective to this evolving field as part of our ongoing AI In Action series.
Read full story
